Education
About Us
Working with TipRanks
Follow Us
Zivo Bioscience (ZIVO)
:ZIVO
Total Valuation
Zivo Bioscience has a market cap or net worth of $54.23M. The enterprise value is $5.52M.
Market Cap$54.23M
Enterprise Value$5.52M
Share Statistics
Zivo Bioscience has 3,813,517 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,813,517
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Zivo Bioscience’s return on equity (ROE) is -8.77 and return on invested capital (ROIC) is 5128.62%.
Return on Equity (ROE)-8.77
Return on Assets (ROA)-8.15
Return on Invested Capital (ROIC)5128.62%
Return on Capital Employed (ROCE)33.51
Revenue Per Employee22.46K
Profits Per Employee-1.91M
Employee Count7
Asset Turnover0.10
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Zivo Bioscience is -5.48. Zivo Bioscience’s PEG ratio is <0.01.
PE Ratio-5.48
PS Ratio0.00
PB Ratio-0.07
Price to Fair Value48.02
Price to FCF-0.16
Price to Operating Cash Flow-0.16
PEG Ratio<0.01
Income Statement
In the last 12 months, Zivo Bioscience had revenue of 157.22K and earned -13.38M in profits. Earnings per share was -3.92.
Revenue157.22K
Gross Profit48.95K
Operating Income-13.36M
Pretax Income-13.38M
Net Income-13.38M
EBITDA-13.36M
Earnings Per Share (EPS)-3.92
Cash Flow
In the last 12 months, operating cash flow was -4.04M and capital expenditures 0.00, giving a free cash flow of -4.04M billion.
Operating Cash Flow-4.04M
Free Cash Flow-4.04M
Free Cash Flow per Share-1.06
Dividends & Yields
Zivo Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.52
52-Week Price Change77.75%
50-Day Moving Average16.21
200-Day Moving Average17.99
Relative Strength Index (RSI)39.80
Average Volume (3m)529.00
Important Dates
Zivo Bioscience upcoming earnings date is Mar 15, 2024, TBA Not Confirmed.
Last Earnings DateNov 13, 2023
Next Earnings DateMar 15, 2024
Ex-Dividend Date―
Financial Position
Zivo Bioscience as a current ratio of 0.80, with Debt / Equity ratio of -63.32%
Current Ratio0.80
Quick Ratio0.80
Debt to Market Cap<0.01
Net Debt to EBITDA0.10
Interest Coverage Ratio-582.50
Taxes
In the past 12 months, Zivo Bioscience has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Zivo Bioscience EV to EBITDA ratio is -5.39, with an EV/FCF ratio of -16.70.
EV to Sales458.19
EV to EBITDA-5.39
EV to Free Cash Flow-16.70
EV to Operating Cash Flow-16.70
Balance Sheet
Zivo Bioscience has $517.19K in cash and marketable securities with $893.13K in debt, giving a net cash position of $375.95K billion.
Cash & Marketable Securities$517.19K
Total Debt$893.13K
Net Cash$375.95K
Net Cash Per Share$0.10
Tangible Book Value Per Share-$0.15
Margins
Gross margin is 0.00%, with operating margin of -8498.85%, and net profit margin of -8513.44%.
Gross Margin0.00%
Operating Margin-8498.85%
Pretax Margin-8513.44%
Net Profit Margin-8513.44%
EBITDA Margin-8498.85%
EBIT Margin-8498.85%
Analyst Forecast
The average price target for Zivo Bioscience is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast398.55%
EPS Growth Forecast8.27%